KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY;ENZYCHEM LIFESCIENCES CORPORATION
发明人:
KIM, JAE WHA,OH, SEI RYANG,AHN, KYUNG SEOP,KANG, HO BUM,PARK, BEOM SU,KANG, JONG KOO,JUNG, YOUNG SIK,SOHN, KI-YOUNG
申请号：
CA2921845
公开号：
CA2921845A1
申请日:
2014.08.18
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to a pharmaceutical composition for preventing, treating, or alleviating rheumatoid arthritis, a composition for a functional health food, and a medicinal compound. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting phosphorylation of STAT-3, which is known as a target material in treating rheumatoid arthritis, and thus can overcome side effects of currently used therapeutic agents for rheumatoid arthritis. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, and alleviating rheumatoid arthritis.
